ArticleAntibodies (Basel, Switzerland)2018

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.

Elie Dheilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.